How to Minimize Heart Problems Following Cancer Treatment

blood pressure cuffAs more people are surviving cancer than ever before, greater attention is being focused on the cardiotoxicity of therapies and their long-term effects on the heart.

Radiation therapy and a number of commonly used chemotherapy drugs can impair heart function, says Anju Nohria, MD, a cardiologist who leads the cardio-oncology program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). The drugs can also worsen heart conditions that patients had prior to their cancer treatment.

Chemotherapy drugs known as anthracyclines, including doxorubicin (Adriamycin), used in treating breast, lung, and ovarian cancer, and some leukemias and lymphomas, can damage heart muscles. Trastuzumab (Herceptin), a breast cancer drug, can also be toxic to the heart. Ibrutinib, a blood cancer drug, may cause atrial fibrillation, and there is a risk of high blood pressure from treatment with certain targeted drugs. The newer class of immunotherapy agents called checkpoint inhibitors can cause myocarditis, an inflammation of the heart muscle. These conditions may lead to heart failure, when the heart is too weak to supply the body with sufficient oxygen.

Recently, the American Society of Clinical Oncology (ASCO) issued guidelines to clarify best practices for preventing and monitoring heart problems in survivors of adult-onset cancers. These guidelines suggest avoiding cardiotoxic treatments, including those mentioned above, for patients with heart disease or cardiac risk factors, if alternatives can be substituted without compromising patient outcomes.

When alternatives can’t safely be used, oncologists are advised to take steps to minimize the heart’s exposure to certain drugs and to radiation. One strategy is to use lower doses of cancer drugs, in combination with medications to help protect the heart. Radiation therapy can also be modified to avoid radiating the whole chest in some cases. Another measure during radiation is for patients to take deep breaths and hold them, which keeps the heart out of the direct path of the radiation beam. Nevertheless, “you have to make sure the cancer is appropriately treated,” Nohria stresses.

With more people living longer following cancer treatment, survivors should be monitored for signs that their heart is not functioning normally as a result of treatment, Nohria says. Recent studies suggest that in most cases, damage from anthracycline chemotherapy drugs is likely to appear within the first post-treatment year. Therefore, cardiologists recommend heart function be tested with an echocardiogram before treatment starts and again one year following treatment.

“If you catch these problems early, you may be able to delay the onset of serious symptoms, or even reverse the damage by giving drugs like beta blockers or ACE inhibitors,” Nohria says.

Learn more about adult survivorship care.

Comments Sort By Newest

One thought on “How to Minimize Heart Problems Following Cancer Treatment

  1. It’s tough to see and read what cancer patients go through, and then to follow that up with heart problems! Stay strong!

  2. It’s tough to see and read what cancer patients go through, and then to follow that up with heart problems! Stay strong!

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Most Read Stories

Sorry. No data so far.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
9/27: Join Dana-Farber's Dr. Lewis Silverman to hear the latest in pediatric acute lymphoblastic #leukemia research… https://t.co/1FkU2v2smy
Dana-Farber @danafarber
Meet Caron Jacobson, MD: Principal investigator for a CAR T-cell trial for diffuse large B-cell #lymphoma.… https://t.co/UeSeVQEhEY
Dana-Farber @danafarber
Former Dana-Farber cancer patients (now survivors) share their advice for patients new to treatment. Read more:… https://t.co/VDZmU8ZZve

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.